Loading Events

« All Events

  • This event has passed.

The Ethical Involvement of Patients in FDA Regulatory Evaluation of New Products

September 9, 2016 @ 12:30 pm - 2:00 pm

There is a growing push to incorporate patient voices more directly at the FDA in decision-making about investigational drugs, but what are the optimal parameters of patients’ contributions?

  • How should individual patient voices be weighed against the accumulated data about a drug?
  • Can we better educate patients to equip them to engage in discussions about trial design, statistics, and evaluation?
  • How should we consider financial relationships between patient advocacy groups and the pharmaceutical industry sponsor of a drug?

To address these and other questions, we will consider two recent cases: flibanserin (the “female Viagra”) for hypoactive sexual desire disorder in women and eteplirsen for Duchenne muscular dystrophy. In both cases, patients had a substantial voice in the data collection and FDA review processes, leading to controversial outcomes.

 

Please register here.

Registration is required for non-Harvard guests.
Please bring your ID due to building security.
A light lunch will be served.

Details

Date:
September 9, 2016
Time:
12:30 pm - 2:00 pm
Event Category:
Website:
http://campaign.r20.constantcontact.com/render?m=1121322547811&ca=5205a09e-c594-40be-adfa-b06035369eeb

Organizer

Center for Bioethics
View Organizer Website

Venue

Waterhouse Room, Gordon Hall 106
25 Shattuck Street
Boston, MA 02115 United States
+ Google Map